These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5933381)

  • 1. Antibacterial management of infections due to gram-negative bacilli. II. Use of the teteracyclines, chloramphenicol, polymyxin B, cycloserine, and paromomycin.
    Martin WJ
    Surg Gynecol Obstet; 1966 May; 122(5):997-1002. PubMed ID: 5933381
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial management of infections due to gram-negative bacilli. I. Introduction, pathogens, and use of streptomycin, dihydrostreptomycin, neomycin, kanamycin and gentamicin.
    Martin WJ
    Minn Med; 1966 May; 49(5):835-40. PubMed ID: 5932785
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibacterial management of infection due to gram-negative bacilli. VI. Some infections of the nervous system, skeletal system, hematopoietic system, skin, and soft tissues and comment.
    Martin WJ
    Minn Med; 1966 Oct; 49(10):1603-8. PubMed ID: 5331538
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibacterial management of infection due to gram-negative bacilli. 3. Use of ampicillin, the cephalosporins, spectinomycin, and chemotherapy.
    Martin WJ
    Minn Med; 1966 Jul; 49(7):1161-7. PubMed ID: 4223094
    [No Abstract]   [Full Text] [Related]  

  • 5. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B: similarities to and differences from colistin (polymyxin E).
    Kwa A; Kasiakou SK; Tam VH; Falagas ME
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Choice and use of drugs from the standpoint of the antibacterial spectrum--Gram-negative bacillus infections].
    Kitamoto O; Fukaya K
    Naika; 1967 Aug; 20(2):224-31. PubMed ID: 5586773
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
    Alipour M; Halwani M; Omri A; Suntres ZE
    Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria.
    Teng CB; Koh PT; Lye DC; Ang BS
    Int J Antimicrob Agents; 2008 Jan; 31(1):80-2. PubMed ID: 17920246
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibacterial management of infections due to gram-negative bacilli. IV. Principles of management, empiric therapy, and some infections of the respiratory tract.
    Martin WJ
    Minn Med; 1966 Aug; 49(8):1309-13. PubMed ID: 5945116
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibacterial chemotherapy in surgical practice: recent acquistitions and critical considerations].
    Petterle F
    Friuli Med; 1968; 23(4):515-68. PubMed ID: 4976383
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.
    Sobieszczyk ME; Furuya EY; Hay CM; Pancholi P; Della-Latta P; Hammer SM; Kubin CJ
    J Antimicrob Chemother; 2004 Aug; 54(2):566-9. PubMed ID: 15269195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taking inventory: antibacterial agents currently at or beyond phase 1.
    Bush K; Macielag M; Weidner-Wells M
    Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B.
    Pereira GH; Muller PR; Levin AS
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):235-40. PubMed ID: 17350201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novelties in the field of anti-infective compounds in 1999.
    Bryskier A
    Clin Infect Dis; 2000 Dec; 31(6):1423-66. PubMed ID: 11096013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bactericidal test: past, present, and future use in the management of patients with infections.
    Vosti K
    Curr Clin Top Infect Dis; 1989; 10():43-55. PubMed ID: 2679699
    [No Abstract]   [Full Text] [Related]  

  • 17. Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit.
    Toltzis P
    Minerva Pediatr; 2003 Oct; 55(5):385-93. PubMed ID: 14608262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency, characteristics and outcome of infections in patients with acute nonlymphoblastic leukemias.
    Savić A; Pejin D; Stefanović N; Popović S
    Med Pregl; 1999; 52(11-12):475-83. PubMed ID: 10748771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
    Zavascki AP; Goldani LZ; Li J; Nation RL
    J Antimicrob Chemother; 2007 Dec; 60(6):1206-15. PubMed ID: 17878146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotherapy of infection.
    Rollo IM
    Manit Med Rev; 1968 Dec; 48(10):445-8. PubMed ID: 5701323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.